Home2025May21Biotech company Regeneron to buy bankrupt 23andMe for $256M – Ars Technica $GOOG $NVDA $MSFT Biotech company Regeneron to buy bankrupt 23andMe for $256M – Ars Technica $GOOG $NVDA $MSFT May 21, 2025betadmin Regeneron will use trove of 23andMe genetic data to develop medical advances. #stockmarket #breaking
Got $3,000? 3 Artificial Intelligence (AI) Stocks to Buy and Hold for the Long Term – The Motley Fool The AI arms race is set to continue well past 2026. #stockmarket #breaking
Stock futures are under pressure again as Tesla, IBM fall on earnings, oil jumps: Live updates – CNBC $TSLA #Tesla Investors continue to watch earnings releases from the biggest U.S. companies, which many believe could be make-or-break for the current…
Fintech company Block lays off 4,000 of its 10,000 staff, citing gains from AI – AP News Shares in the financial technology company Block have soared more than 20% in after-hours trading after its CEO announced it…